You are here: Industry Insights > Pfizer

News List

Pfizer inks $23.8M deal to settle Justice Department's charity kickback probe fiercepharma
May 28, 2018
Targeted by the Justice Department in an industrywide copay assistance investigation, Pfizer has now agreed to a $23.85 million settlement with the feds
Pfizer begins testing RSV vaccine in healthy adults pharmatimes
May 24, 2018
The company is looking to develop the vaccine for populations at highest risk of the respiratory infection - infants through maternal immunisation and older adults through direct vaccination.
Pfizer begins testing RSV vaccine in healthy adults pharmatimes
May 24, 2018
The company is looking to develop the vaccine for populations at highest risk of the respiratory infection - infants through maternal immunisation and older adults through direct vaccination.
Up-and-coming Pfizer, AbbVie drugs set to threaten Amgen, Celgene fiercepharma
May 23, 2018
With Pfizer’s Xeljanz snapping up new indications and AbbVie’s upadacitinib on the way, makers of anti-inflammatory drugs will soon feel the heat from JAK inhibitors if they haven't already. But some will feel it more than others, Bernstein analysts say.
Pfizer's Epilepsy medication Lyrica gives positive results in pediatric study biospectrumasia
May 21, 2018
LYRICA is currently approved for various indications in more than 130 countries and regions globally
Pfizer vet Travis Wager takes R&D reins at Aquinnah fiercebiotech
May 16, 2018
Neuro biotech Aquinnah Pharmaceuticals has a new vice president of research: Travis Wager, Ph.D., who wore various hats during his 20-year tenure at Pfizer.
Pfizer eyes AI-powered drug discovery and development software newsnow
May 14, 2018
Its collaboration with Cambridge, Massachusetts-based XtalPi will see the firms work on molecular modelling software that can be applied to drug-like small molecules.
Pfizer selects two targets under partnership with Wave biospectrumasia
May 09, 2018
Pfizer has nominated the fourth and fifth targets of the collaboration, designed to apply Wave’s stereochemistry platform across antisense and single-stranded RNA interference (RNAi) modalities
Where is Pfizer putting its R&D hopes? Vaccines are front and center fiercepharma
May 08, 2018
On Pfizer’s first-quarter earnings call, CEO Ian Read drew up a long list of R&D programs the company’s expecting to drive future growth. But when Bernstein analyst Tim Anderson asked him to narrow it down, Read mentioned vaccines first.
Pfizer culls 5 experimental cancer trials and an acne drug in Q1 clear out fiercebiotech
May 02, 2018
Pfizer has cleared out five early stage oncology drug tests from its pipeline, including three tests for utomilumab, as well as an acne drug.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page